Market Closed -
BOERSE MUENCHEN
15:43:23 2024-05-31 EDT
|
5-day change
|
1st Jan Change
|
11.74
EUR
|
-.--%
|
|
+2.44%
|
-4.94%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
21,221
|
18,071
|
15,374
|
11,668
|
11,946
|
10,988
|
-
|
-
|
Enterprise Value (EV)
1 |
22,991
|
19,999
|
17,423
|
14,190
|
14,728
|
13,543
|
13,220
|
12,896
|
P/E ratio
|
35.5
x
|
40.3
x
|
29.3
x
|
52.6
x
|
45.6
x
|
21.4
x
|
16.4
x
|
13.9
x
|
Yield
|
1.54%
|
1.82%
|
2.14%
|
2.79%
|
2.73%
|
3%
|
3.38%
|
3.83%
|
Capitalization / Revenue
|
4.13
x
|
3.96
x
|
2.95
x
|
2.24
x
|
2.15
x
|
1.89
x
|
1.79
x
|
1.7
x
|
EV / Revenue
|
4.47
x
|
4.39
x
|
3.34
x
|
2.72
x
|
2.65
x
|
2.33
x
|
2.16
x
|
2
x
|
EV / EBITDA
|
14.9
x
|
18
x
|
13
x
|
10.7
x
|
10.1
x
|
9.19
x
|
8.13
x
|
7.51
x
|
EV / FCF
|
30.3
x
|
40.6
x
|
37.1
x
|
129
x
|
81.4
x
|
24
x
|
19
x
|
17
x
|
FCF Yield
|
3.31%
|
2.46%
|
2.69%
|
0.78%
|
1.23%
|
4.16%
|
5.28%
|
5.87%
|
Price to Book
|
4.15
x
|
3.43
x
|
2.76
x
|
2.23
x
|
2.29
x
|
2.04
x
|
1.94
x
|
1.85
x
|
Nbr of stocks (in thousands)
|
873,334
|
875,215
|
878,536
|
869,496
|
870,199
|
871,947
|
-
|
-
|
Reference price
2 |
24.30
|
20.65
|
17.50
|
13.42
|
13.73
|
12.60
|
12.60
|
12.60
|
Announcement Date
|
20-02-20
|
21-02-18
|
22-02-22
|
23-02-21
|
24-02-27
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,138
|
4,560
|
5,212
|
5,215
|
5,549
|
5,816
|
6,122
|
6,447
|
EBITDA
1 |
1,544
|
1,108
|
1,345
|
1,324
|
1,464
|
1,473
|
1,627
|
1,718
|
EBIT
1 |
1,169
|
683
|
936
|
901
|
970
|
1,059
|
1,219
|
1,333
|
Operating Margin
|
22.75%
|
14.98%
|
17.96%
|
17.28%
|
17.48%
|
18.21%
|
19.92%
|
20.67%
|
Earnings before Tax (EBT)
1 |
743
|
246
|
586
|
235
|
290
|
635.5
|
816.8
|
955.2
|
Net income
1 |
600
|
448
|
524
|
223
|
263
|
540.2
|
692.6
|
783.2
|
Net margin
|
11.68%
|
9.82%
|
10.05%
|
4.28%
|
4.74%
|
9.29%
|
11.31%
|
12.15%
|
EPS
2 |
0.6840
|
0.5120
|
0.5970
|
0.2550
|
0.3010
|
0.5879
|
0.7690
|
0.9071
|
Free Cash Flow
1 |
760
|
492
|
469
|
110
|
181
|
563.9
|
697.4
|
756.8
|
FCF margin
|
14.79%
|
10.79%
|
9%
|
2.11%
|
3.26%
|
9.7%
|
11.39%
|
11.74%
|
FCF Conversion (EBITDA)
|
49.22%
|
44.4%
|
34.87%
|
8.31%
|
12.36%
|
38.29%
|
42.88%
|
44.05%
|
FCF Conversion (Net income)
|
126.67%
|
109.82%
|
89.5%
|
49.33%
|
68.82%
|
104.4%
|
100.7%
|
96.64%
|
Dividend per Share
2 |
0.3750
|
0.3750
|
0.3750
|
0.3750
|
0.3750
|
0.3786
|
0.4255
|
0.4828
|
Announcement Date
|
20-02-20
|
21-02-18
|
22-02-22
|
23-02-21
|
24-02-27
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
2,653
|
2,035
|
2,525
|
2,599
|
1,266
|
1,346
|
2,613
|
1,306
|
1,293
|
2,600
|
1,250
|
1,365
|
2,615
|
1,356
|
1,379
|
2,734
|
1,357
|
1,458
|
2,815
|
1,398
|
1,450
|
2,830
|
1,425
|
1,558
|
2,988
|
1,464
|
2,994
|
3,142
|
EBITDA
|
825
|
360
|
748
|
666
|
-
|
-
|
679
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
637
|
172
|
511
|
459
|
-
|
-
|
477
|
-
|
-
|
440
|
-
|
-
|
461
|
-
|
-
|
417
|
-
|
-
|
553
|
-
|
-
|
466.5
|
-
|
-
|
551.6
|
-
|
596
|
644
|
Operating Margin
|
24.01%
|
8.45%
|
20.24%
|
17.66%
|
-
|
-
|
18.25%
|
-
|
-
|
16.92%
|
-
|
-
|
17.63%
|
-
|
-
|
15.25%
|
-
|
-
|
19.64%
|
-
|
-
|
16.49%
|
-
|
-
|
18.46%
|
-
|
19.91%
|
20.5%
|
Earnings before Tax (EBT)
|
360
|
-34
|
280
|
223
|
-
|
-
|
-
|
-
|
-
|
204
|
-
|
-
|
31
|
-
|
-
|
211
|
-
|
-
|
79
|
-
|
-
|
256
|
-
|
-
|
392.5
|
-
|
399
|
446
|
Net income
|
291
|
100
|
348
|
205
|
-
|
-
|
319
|
-
|
-
|
177
|
-
|
-
|
46
|
-
|
-
|
171.6
|
-
|
-
|
91
|
-
|
-
|
206
|
-
|
-
|
316
|
-
|
321
|
359
|
Net margin
|
10.97%
|
4.91%
|
13.78%
|
7.89%
|
-
|
-
|
12.21%
|
-
|
-
|
6.81%
|
-
|
-
|
1.76%
|
-
|
-
|
6.28%
|
-
|
-
|
3.23%
|
-
|
-
|
7.28%
|
-
|
-
|
10.57%
|
-
|
10.72%
|
11.43%
|
EPS
|
0.3320
|
0.1140
|
0.3980
|
0.2330
|
-
|
-
|
0.3640
|
-
|
-
|
0.2020
|
-
|
-
|
0.0530
|
-
|
-
|
0.1970
|
-
|
-
|
0.1040
|
-
|
-
|
0.2200
|
-
|
-
|
0.3700
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1440
|
-
|
-
|
0.2310
|
-
|
-
|
0.1440
|
-
|
-
|
0.2310
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-20
|
20-07-29
|
21-02-18
|
21-07-29
|
21-11-04
|
22-02-22
|
22-02-22
|
22-04-28
|
22-07-28
|
22-07-28
|
22-11-03
|
23-02-21
|
23-02-21
|
23-05-03
|
23-08-03
|
23-08-03
|
23-11-02
|
24-02-27
|
24-02-27
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,770
|
1,928
|
2,049
|
2,522
|
2,782
|
2,555
|
2,232
|
1,908
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.146
x
|
1.74
x
|
1.523
x
|
1.905
x
|
1.9
x
|
1.735
x
|
1.372
x
|
1.111
x
|
Free Cash Flow
1 |
760
|
492
|
469
|
110
|
181
|
564
|
697
|
757
|
ROE (net income / shareholders' equity)
|
17.8%
|
10.8%
|
13.1%
|
13.2%
|
13.8%
|
14.1%
|
15.7%
|
16.7%
|
ROA (Net income/ Total Assets)
|
10.3%
|
5.55%
|
6.47%
|
6.83%
|
7.24%
|
6.2%
|
7.85%
|
8.5%
|
Assets
1 |
5,831
|
8,072
|
8,093
|
3,266
|
3,634
|
8,712
|
8,823
|
9,214
|
Book Value Per Share
2 |
5.860
|
6.020
|
6.350
|
6.030
|
5.990
|
6.180
|
6.500
|
6.810
|
Cash Flow per Share
2 |
1.330
|
1.070
|
1.000
|
0.5400
|
0.7000
|
1.270
|
1.440
|
1.180
|
Capex
1 |
408
|
443
|
408
|
358
|
427
|
449
|
466
|
485
|
Capex / Sales
|
7.94%
|
9.71%
|
7.83%
|
6.86%
|
7.7%
|
7.71%
|
7.61%
|
7.52%
|
Announcement Date
|
20-02-20
|
21-02-18
|
22-02-22
|
23-02-21
|
24-02-27
|
-
|
-
|
-
|
Last Close Price
12.6
USD Average target price
16.35
USD Spread / Average Target +29.71% Consensus |
1st Jan change
|
Capi.
|
---|
| +13.73% | 130B | | -4.33% | 8.42B | | +41.80% | 5.57B | | -21.94% | 4.59B | | +7.81% | 3.42B | | -10.26% | 2.73B | | -10.29% | 2.08B | | -13.58% | 1.92B | | -27.77% | 1.66B |
Medical Devices & Implants
|